logo logo

Biotechnology Templates

  • HOME
  • /
  • ABOUT ISAP BIOTECH
    • Company Profile
  • /
  • SCIENTIFIC RESEARCH
    • Pipeline
    • Technology Platform
    • Publication
  • /
  • NEWS
    • Company News
  • /
  • CONTACT
  • CN
  • EN
ABOUT US

Isap Biotech is dedicated to pioneering the discovery and development of innovative Peptide-Drug Conjugates (PDCs). By leveraging our proprietary nanobiotechnology platform and advanced peptide design platform, we aim to address unmet medical needs through new solutions.

NEWS

Isap Biotech to Present Two Research Breakthroughs at AACR 2025

2025-04-09
Beijing, April 9, 2025, Isap Biotech, an emerging leader in conjugate drug development, today announced that preclinical data for two of its novel drug candidates have been selected for poster pres...

Isap Biotech Receives CDE Clinical Trial Approval for iSAP-0909: A Novel Pan-Tumor Fluorescent Contrast Agent

2025-03-06
Beijing, March 3, 2025, Isap Biotech announced that its self-developed lead product, iSAP-0909 for injection, has been officially greenlighted by China's National Medical Products Administration (N...

Isap Biotech's Innovative Pan-Tumor Fluorescent Imaging Agent iSAP-0909 Secures FDA Approval for Clinical Trials

2024-11-04
Beijing, October 31, 2024, Isap Biotech announces FDA IND clearance for iSAP-0909 for injection, a potential First-in-Class pan-tumor targeted imaging agent Isap Biotech announced that its lead can...
1
  • HOME
    • ABOUT ISAP BIOTECH
      • Company Profile
      • SCIENTIFIC RESEARCH
        • Pipeline
          • Technology Platform
            • Publication
            • NEWS
              • Company News
              • CONTACT


                Contract Address: Room 405, 4th Floor, Building 2, No. 9 Courtyard, Yike Road, Life Science Park, Changping District, Beijing, China.

                Email: info@isapbiotech.com

                ©2025 - Isap Biotech